ABOUT US
THERAPEUTIC APPROACH
TEAM
PARTNERS CONTACT US


PARTNERS

Yuma has been awarded a grant from the Alzheimer Drug Discovery Foundation (ADDF) to identify disease-modifying lead drug candidate for treating Alzheimer's disease.  The partnership with the ADDF also benefits Yuma through access to the ADDF's extensive network of scientific experts in AD. For more information on the ADDF, please visit www.alzdiscovery.org

Copyright 2011, Yuma Therapeutics Corporation